Browsing Tag
biotech acquisitions
3 posts
How Astria Therapeutics’ sale signals a valuation reset for late-stage hereditary angioedema drug assets
Astria Therapeutics’ sale highlights a valuation reset for late-stage rare disease drug assets. Read how this deal reshapes biotech M&A strategy.
Zinzino AB announces acquisition of Sanki to enhance wellness presence throughout Americas
Zinzino AB to acquire Sanki for USD 8 million to expand wellness distribution across the Americas. Discover what this means for its global test-based health strategy.
OSR Holdings completes merger, set to begin Nasdaq trading on February 18
OSR Holdings, Inc. has officially completed its business combination with OSR Holdings Co., Ltd., marking a pivotal milestone…